Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable cytochrome P450 141 Cyp141 | 0.0013 | 0.0833 | 0.5 |
Schistosoma mansoni | cytochrome P450 | 0.0013 | 0.0833 | 0.0833 |
Brugia malayi | Bloom's syndrome protein homolog | 0.002 | 0.2804 | 0.2151 |
Brugia malayi | Cytochrome P450 family protein | 0.0023 | 0.3746 | 0.3178 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0035 | 0.7177 | 0.7146 |
Brugia malayi | ATP-dependent DNA helicase, RecQ family protein | 0.002 | 0.2804 | 0.2151 |
Mycobacterium tuberculosis | Probable cytochrome P450 128 Cyp128 | 0.0013 | 0.0833 | 0.5 |
Entamoeba histolytica | recQ family DNA helicase | 0.001 | 0.0107 | 0.0381 |
Echinococcus multilocularis | ATP dependent DNA helicase Q5 | 0.002 | 0.2804 | 0.2151 |
Schistosoma mansoni | DNA helicase recq5 | 0.002 | 0.2804 | 0.2804 |
Mycobacterium tuberculosis | Possible cytochrome P450 126 Cyp126 | 0.0013 | 0.0833 | 0.5 |
Treponema pallidum | ATP-dependent DNA helicase | 0.001 | 0.0107 | 0.5 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0023 | 0.3746 | 0.3678 |
Mycobacterium tuberculosis | Probable cytochrome P450 monooxygenase 142 Cyp142 | 0.0013 | 0.0833 | 0.5 |
Echinococcus granulosus | ATP dependent DNA helicase Q5 | 0.002 | 0.2804 | 0.2151 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.002 | 0.2804 | 1 |
Mycobacterium tuberculosis | Possible cytochrome P450 135B1 Cyp135B1 | 0.0013 | 0.0833 | 0.5 |
Schistosoma mansoni | DNA helicase recq1 | 0.002 | 0.2804 | 0.2804 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0045 | 1 | 1 |
Brugia malayi | Cytochrome P450 family protein | 0.0023 | 0.3746 | 0.3178 |
Mycobacterium tuberculosis | Cytochrome P450 121 Cyp121 | 0.0013 | 0.0833 | 0.5 |
Toxoplasma gondii | cytochrome p450 superfamily protein | 0.0013 | 0.0833 | 0.2969 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0045 | 1 | 1 |
Trypanosoma cruzi | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.002 | 0.2804 | 0.7412 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0023 | 0.3746 | 0.3678 |
Mycobacterium tuberculosis | Probable cytochrome P450 143 Cyp143 | 0.0013 | 0.0833 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 1 | 1 |
Mycobacterium tuberculosis | Probable cytochrome P450 130 Cyp130 | 0.0013 | 0.0833 | 0.5 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.002 | 0.2804 | 1 |
Schistosoma mansoni | blooms syndrome DNA helicase | 0.001 | 0.0107 | 0.0107 |
Giardia lamblia | Sgs1 DNA helicase, putative | 0.002 | 0.2804 | 0.5 |
Trypanosoma cruzi | Lanosterol 14-alpha demethylase | 0.0013 | 0.0833 | 0.1995 |
Loa Loa (eye worm) | cytochrome P450 | 0.0013 | 0.0833 | 0.0734 |
Trypanosoma cruzi | cytochrome p450-like protein, putative | 0.0013 | 0.0833 | 0.1995 |
Plasmodium falciparum | ATP-dependent DNA helicase Q1 | 0.002 | 0.2804 | 0.5 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.001 | 0.0107 | 0.0381 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0013 | 0.0833 | 0.5 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0023 | 0.3746 | 1 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.002 | 0.2804 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 137 Cyp137 | 0.0013 | 0.0833 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 132 Cyp132 | 0.0013 | 0.0833 | 0.5 |
Echinococcus multilocularis | bloom syndrome protein | 0.002 | 0.2804 | 0.2151 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0216 | 0.011 |
Mycobacterium tuberculosis | Probable cytochrome P450 125 Cyp125 | 0.0013 | 0.0833 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 140 Cyp140 | 0.0013 | 0.0833 | 0.5 |
Mycobacterium leprae | putative cytochrome p450 | 0.0013 | 0.0833 | 0.5 |
Mycobacterium tuberculosis | Possible cytochrome P450 135A1 Cyp135A1 | 0.0013 | 0.0833 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0045 | 1 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0045 | 1 | 1 |
Trypanosoma brucei | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.002 | 0.2804 | 0.6768 |
Mycobacterium tuberculosis | Probable cytochrome P450 124 Cyp124 | 0.0013 | 0.0833 | 0.5 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0023 | 0.3746 | 1 |
Mycobacterium tuberculosis | Probable cytochrome P450 144 Cyp144 | 0.0013 | 0.0833 | 0.5 |
Echinococcus granulosus | ATP dependent DNA helicase Q1 | 0.002 | 0.2804 | 0.2151 |
Trichomonas vaginalis | DNA helicase recq1, putative | 0.002 | 0.2804 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 123 Cyp123 | 0.0013 | 0.0833 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 136 Cyp136 | 0.0013 | 0.0833 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0045 | 1 | 1 |
Plasmodium falciparum | ADP-dependent DNA helicase RecQ | 0.002 | 0.2804 | 0.5 |
Brugia malayi | ATP-dependent DNA helicase, RecQ family protein | 0.002 | 0.2804 | 0.2151 |
Loa Loa (eye worm) | ATP-dependent DNA helicase | 0.002 | 0.2804 | 0.2726 |
Brugia malayi | Cytochrome P450 family protein | 0.0035 | 0.7177 | 0.692 |
Loa Loa (eye worm) | RecQ helicase | 0.002 | 0.2804 | 0.2726 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 1 | 1 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0023 | 0.3746 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0013 | 0.0833 | 0.0833 |
Echinococcus multilocularis | ATP dependent DNA helicase Q1 | 0.002 | 0.2804 | 0.2151 |
Mycobacterium tuberculosis | Probable cytochrome P450 139 Cyp139 | 0.0013 | 0.0833 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 138 Cyp138 | 0.0013 | 0.0833 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 1 | 1 |
Trypanosoma brucei | cytochrome P450, putative | 0.0023 | 0.3746 | 1 |
Mycobacterium tuberculosis | Cytochrome P450 51 Cyp51 (CYPL1) (P450-L1A1) (sterol 14-alpha demethylase) (lanosterol 14-alpha demethylase) (P450-14DM) | 0.0013 | 0.0833 | 0.5 |
Plasmodium vivax | ADP-dependent DNA helicase RecQ, putative | 0.001 | 0.0107 | 1 |
Entamoeba histolytica | recQ family helicase, putative | 0.002 | 0.2804 | 1 |
Leishmania major | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.002 | 0.2804 | 0.6768 |
Echinococcus granulosus | bloom syndrome protein | 0.002 | 0.2804 | 0.2151 |
Leishmania major | cytochrome p450-like protein | 0.0023 | 0.3746 | 1 |
Trypanosoma cruzi | Lanosterol 14-alpha demethylase | 0.0013 | 0.0833 | 0.1995 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.002 | 0.2804 | 0.5 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0023 | 0.3746 | 0.3678 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0107 | 0.000000002293 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.2804 | 0.2726 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 22 % | Antiinflammatory activity in LPS-stimulated human THP1 cells assessed as inhibition of IL6 formation at 1 uM pretreated 30 mins before LPS challenge measured after 24 hrs by ELISA | ChEMBL. | 20207143 |
Activity (functional) | = 78 % | Antiinflammatory activity in LPS-stimulated human THP1 cells assessed as inhibition of TNFalpha formation at 10 uM pretreated 30 mins before LPS challenge measured after 24 hrs by ELISA | ChEMBL. | 20207143 |
Activity (functional) | = 98 % | Antiinflammatory activity in LPS-stimulated human THP1 cells assessed as inhibition of IL6 formation at 10 uM pretreated 30 mins before LPS challenge measured after 24 hrs by ELISA | ChEMBL. | 20207143 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.